Dr Lal Path Labs Dividend 2026: Dr Lal Path Labs on Thursday (April 30) declared its Q4 quarterly results for financial year 2025-26. Along with the quarterly earnings, the BSE 500 company also declared a final dividend of Rs 4 per equity share for FY26.
Profit for Q4 FY26 was Rs 131 crore against Rs 155 crore in Q4 FY25, registering a year-on-year decline of 15.5 per cent.
EBITDA came in at Rs 186.6 crore in Q4 FY26 versus Rs 169.4 crore in Q4 FY25, up 10.2 per cent year-on-year. EBITDA margin stood at 26.5 per cent in Q4 FY26 compared to 28.1 per cent in Q4 FY25.
The company has recommended a final dividend of Rs 4 per share.
“Recommendation of final dividend of INR 4/- per equity share (@ 40% on a face value of INR 10/- each) for the financial year ended March 31, 2026, subject to approval of the Members of the Company at ensuing Annual General Meeting (“AGM”),” the company said in its exchange filing.
The record date for the purpose of payment of final dividend shall be June 26, 2026
The company also announced acquisition of 100 per cent stake in Shahbazkers Diagnostic Centre Private Limited from its existing Shareholders. Post acquisition, SDCPL shall become a wholly owned subsidiary of the company.
The final dividend will be credited within 30 days of the approval by the Members.
Dr Lal Path Labs Share Price
